Valuation: Unichem Laboratories Limited

Market Cap 35.66B 380M 343M 317M 286M 541M 555M 3.79B 1.51B 19.1B 1.43B 1.4B 60.77B P/E 2025
35.6x
P/E 2026 8.19x
Enterprise Value 37.76B 403M 363M 335M 303M 573M 588M 4.02B 1.6B 20.22B 1.51B 1.48B 64.36B EV / Sales 2025
2.49x
EV / Sales 2026 1.03x
Free-Float
28.71%
Yield 2025 *
-
Yield 2026 -
1 day-0.33%
1 week+0.42%
Current month+4.76%
1 month-4.37%
3 months-0.30%
6 months+31.51%
Current year+14.75%
1 week 490.1
Extreme 490.1
525.95
1 month 462
Extreme 462
540.6
Current year 280
Extreme 280
685.95
1 year 280
Extreme 280
685.95
3 years 280
Extreme 280
949.85
5 years 197.5
Extreme 197.5
949.85
10 years 75.1
Extreme 75.1
949.85
Manager TitleAgeSince
Chief Executive Officer 57 2023-08-09
Director of Finance/CFO - 2024-08-07
Compliance Officer - -
Director TitleAgeSince
Chairman 74 1977-08-21
Director/Board Member 53 2023-08-09
Director/Board Member 57 2023-08-09
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%+0.42%+9.78%+23.87% 382M
-0.51%+0.36%+43.94%+132.25% 1,276B
-1.19%+0.30%+42.98%+87.73% 676B
-0.85%-1.26%+29.28%+109.97% 519B
+0.02%+1.52%+39.21%+68.34% 388B
-1.55%-3.18%+60.06%+42.07% 365B
-1.29%-1.13%+27.54%+56.87% 307B
+0.09%-0.91%+3.19%+35.60% 287B
-0.74%-3.51%+36.41%+73.11% 252B
-0.92%-3.06%+38.01%+125.73% 212B
Average -0.76%+2.18%+33.04%+75.55% 428B
Weighted average by Cap. -0.79%+2.51%+38.31%+93.35%

Financials

2025 2026
Net sales 21.11B 225M 203M 187M 169M 321M 328M 2.25B 895M 11.31B 845M 827M 35.98B 22.02B 235M 212M 195M 177M 334M 343M 2.34B 934M 11.79B 881M 862M 37.53B
Net income 1.38B 14.66M 13.22M 12.21M 11.04M 20.88M 21.4M 146M 58.32M 737M 55.03M 53.86M 2.34B 2.53B 26.96M 24.3M 22.45M 20.29M 38.39M 39.34M 269M 107M 1.35B 101M 99.02M 4.31B
Net Debt 3.7B 39.47M 35.57M 32.87M 29.71M 56.21M 57.6M 394M 157M 1.98B 148M 145M 6.31B 2.11B 22.46M 20.24M 18.7M 16.91M 31.99M 32.78M 224M 89.34M 1.13B 84.3M 82.51M 3.59B
Projected Income Statement - Annual - Unichem Laboratories Limited
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
2,780
Date Price Change Volume
26-11-11 ₹506.45 -0.33% 3,870
26-11-09 ₹508.15 +1.07% 4,382
26-11-08 ₹502.75 -0.04% 759
26-11-06 ₹502.95 +1.89% 4,497
26-11-05 ₹493.60 -2.07% 3,548
  1. Stock Market
  2. Stocks
  3. UNICHEMLAB Stock